Crosstalk between epigenetic readers regulates the MOZ/MORF HAT complexes

Epigenetics

Volumn 9, Issue 2, 2014, Pages

  Klein, Brianna J ^a   Lalonde, Marie Eve ^b   Côté, Jacques ^b   Yang, Xiang Jiao ^c   Kutateladze, Tatiana G ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Acetylation; BRPF; Histone; ING5; KAT6A; KAT6B; MORF; MOZ; PHD; Reader

Indexed keywords

BRPF2 PROTEIN; HEAF6; LIGASE; MONOCYTIC LEUKEMIC ZINC FINGER PROTEIN; MOZ RELATED FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; HISTONE; HISTONE ACETYLTRANSFERASE; KAT6A PROTEIN, HUMAN; KAT6B PROTEIN, HUMAN; NUCLEAR PROTEIN;

ARTICLE; CRYSTAL STRUCTURE; EPIGENETICS; GENE; GENETIC ANALYSIS; HISTONE ACETYLATION; HUMAN; KAT6A GENE; LIGAND BINDING; NOONAN SYNDROME; PROTEIN PROCESSING; PROTEIN SUBUNIT; TUMOR SUPPRESSOR GENE; ACETYLATION; ANIMAL; BRPF; CHEMISTRY; GENETIC EPIGENESIS; GENETICS; ING5; KAT6A; KAT6B; METABOLISM; MORF; MOZ; PHD; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; READING; REVIEW;

ACETYLATION; BRPF; HISTONE; ING5; KAT6A; KAT6B; MORF; MOZ; PHD; READER;

ACETYLATION; ANIMALS; EPIGENESIS, GENETIC; HISTONE ACETYLTRANSFERASES; HUMANS; NUCLEAR PROTEINS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN SUBUNITS; ZINC FINGERS;

EID: 84892587406     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.26792     Document Type: Article

References (71)

1. Sapountzi V, Côté J. MYST-family histone acetyltransferases: beyond chromatin. Cell Mol Life Sci 2011; 68:1147-56; PMID:21132344; http://dx.doi. org/10.1007/s00018-010-0599-9
2. Yang XJ, Ullah M. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells. Oncogene 2007; 26:5408-19; PMID:17694082; http://dx.doi.org/10.1038/sj.onc.1210609
3. Doyon Y, Cayrou C, Ullah M, Landry AJ, Côté V, Selleck W, Lane WS, Tan S, Yang XJ, Côté J. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell 2006; 21:51-64; PMID:16387653; http://dx.doi.org/10.1016/j. molcel.2005.12.007
4. Ullah M, Pelletier N, Xiao L, Zhao SP, Wang K, Degerny C, Tahmasebi S, Cayrou C, Doyon Y, Goh SL, et al. Molecular architecture of quartet MOZ/ MORF histone acetyltransferase complexes. Mol Cell Biol 2008; 28:6828-43; PMID:18794358; http:// dx.doi.org/10.1128/MCB.01297-08
5. Avvakumov N, Côté J. The MYST family of histone acetyltransferases and their intimate links to cancer. Oncogene 2007; 26:5395-407; PMID:17694081; http://dx.doi.org/10.1038/sj.onc.1210608
6. Thomas T, Voss AK. The diverse biological roles of MYST histone acetyltransferase family proteins. Cell Cycle 2007; 6:696-704; PMID:17374998; http:// dx.doi.org/10.4161/cc.6.6.4013
7. Perez-Campo FM, Costa G, Lie-a-Ling M, Kouskoff V, Lacaud G. The MYSTerious MOZ, a histone acetyltransferase with a key role in haematopoiesis. Immunology 2013; 139:161-5; PMID:23347099; http://dx.doi.org/10.1111/imm.12072
8. Voss AK, Collin C, Dixon MP, Thomas T. Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity. Dev Cell 2009; 17:674-86; PMID:19922872; http://dx.doi. org/10.1016/j.devcel.2009.10.006
9. Perez-Campo FM, Borrow J, Kouskoff V, Lacaud G. The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors. Blood 2009; 113:4866-74; PMID:19264921; http://dx.doi.org/10.1182/ blood-2008-04-152017
10. Thomas T, Corcoran LM, Gugasyan R, Dixon MP, Brodnicki T, Nutt SL, Metcalf D, Voss AK. Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells. Genes Dev 2006; 20:1175-86; PMID:16651658; http://dx.doi.org/10.1101/ gad.1382606
11. Katsumoto T, Aikawa Y, Iwama A, Ueda S, Ichikawa H, Ochiya T, Kitabayashi I. MOZ is essential for maintenance of hematopoietic stem cells. Genes Dev 2006; 20:1321-30; PMID:16702405; http://dx.doi. org/10.1101/gad.1393106
12. Crump JG, Swartz ME, Eberhart JK, Kimmel CB. Moz-dependent Hox expression controls segmentspecific fate maps of skeletal precursors in the face. Development 2006; 133:2661-9; PMID:16774997; http://dx.doi.org/10.1242/dev.02435
13. Borrow J, Stanton VP Jr., Andresen JM, Becher R, Behm FG, Chaganti RS, Civin CI, Disteche C, Dubé I, Frischauf AM, et al. The translocation t(8;16) (p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 1996; 14:33-41; PMID:8782817; http:// dx.doi.org/10.1038/ng0996-33
14. Panagopoulos I, Fioretos T, Isaksson M, Samuelsson U, Billström R, Strömbeck B, Mitelman F, Johansson B. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum Mol Genet 2001; 10:395-404; PMID:11157802; http://dx.doi.org/10.1093/hmg/10.4.395
15. Terui K, Sato T, Sasaki S, Kudo K, Kamio T, Ito E. Two novel variants of MOZ-CBP fusion transcripts in spontaneously remitted infant leukemia with t(1;16;8)(p13;p13;p11), a new variant of t(8;16)(p11;p13). Haematologica 2008; 93:1591-3; PMID:18698081; http://dx.doi.org/10.3324/ haematol.13020
16. Boyd EM, Bench AJ, Vaghela KJ, Campbell GN, Chowdhury FB, Gudgin EJ, Scott MA, Erber WN. Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes. Leukemia 2009; 23:1164-7; PMID:19158836; http://dx.doi. org/10.1038/leu.2008.383
17. Chaffanet M, Gressin L, Preudhomme C, Soenen-Cornu V, Birnbaum D, Pébusque MJ. MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer 2000; 28:138-44; PMID:10824998; http://dx.doi.org/10.1002/ (SICI)1098-2264(200006)28:2<138::AIDGCC2> 3.0.CO;2-2
18. Champagne N, Pelletier N, Yang XJ. The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase. Oncogene 2001; 20:404-9; PMID:11313971; http://dx.doi.org/10.1038/ sj.onc.1204114
19. Camós M, Esteve J, Jares P, Colomer D, Rozman M, Villamor N, Costa D, Carrió A, Nomdedéu J, Montserrat E, et al. Gene expression profiling of acute myeloid leukemia with translocation t(8;16) (p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression. Cancer Res 2006; 66:6947-54; PMID:16849538; http://dx.doi. org/10.1158/0008-5472.CAN-05-4601
20. Falk H, Connor T, Yang H, Loft KJ, Alcindor JL, Nikolakopoulos G, Surjadi RN, Bentley JD, Hattarki MK, Dolezal O, et al. An efficient high-throughput screening method for MYST family acetyltransferases, a new class of epigenetic drug targets. J Biomol Screen 2011; 16:1196-205; PMID:22086725; http:// dx.doi.org/10.1177/1087057111421631
21. Kindle KB, Collins HM, Heery DM. MOZ-TIF2-mediated destruction of CBP/p300 is blocked by calpain inhibitor 2. Leukemia 2010; 24:1359-61; PMID:20485379; http://dx.doi.org/10.1038/ leu.2010.92
22. Musselman CA, Lalonde ME, Côté J, Kutateladze TG. Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol 2012; 19:1218-27; PMID:23211769; http://dx.doi.org/10.1038/ nsmb.2436
23. Champagne N, Bertos NR, Pelletier N, Wang AH, Vezmar M, Yang Y, Heng HH, Yang XJ. Identification of a human histone acetyltransferase related to monocytic leukemia zinc finger protein. J Biol Chem 1999; 274:28528-36; PMID:10497217; http://dx.doi.org/10.1074/jbc.274.40.28528
24. Qiu Y, Liu L, Zhao C, Han C, Li F, Zhang J, Wang Y, Li G, Mei Y, Wu M, et al. Combinatorial readout of unmodified H3R2 and acetylated H3K14 by the tandem PHD finger of MOZ reveals a regulatory mechanism for HOXA9 transcription. Genes Dev 2012; 26:1376-91; PMID:22713874; http://dx.doi. org/10.1101/gad.188359.112
25. Ali M, Yan K, Lalonde ME, Degerny C, Rothbart SB, Strahl BD, Côté J, Yang XJ, Kutateladze TG. Tandem PHD fingers of MORF/MOZ acetyltransferases display selectivity for acetylated histone H3 and are required for the association with chromatin. J Mol Biol 2012; 424:328-38; PMID:23063713; http:// dx.doi.org/10.1016/j.jmb.2012.10.004
26. Rokudai S, Laptenko O, Arnal SM, Taya Y, Kitabayashi I, Prives C. MOZ increases p53 acetylation and premature senescence through its complex formation with PML. Proc Natl Acad Sci U S A 2013; 110:3895-900; PMID:23431171; http://dx.doi. org/10.1073/pnas.1300490110
27. Pelletier N, Champagne N, Stifani S, Yang XJ. MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. Oncogene 2002; 21:2729-40; PMID:11965546; http://dx.doi.org/10.1038/sj.onc.1205367
28. Holbert MA, Sikorski T, Carten J, Snowflack D, Hodawadekar S, Marmorstein R. The human monocytic leukemia zinc finger histone acetyltransferase domain contains DNA-binding activity implicated in chromatin targeting. J Biol Chem 2007; 282:36603-13; PMID:17925393; http://dx.doi.org/10.1074/jbc. M705812200
29. Zeng L, Zhang Q, Li S, Plotnikov AN, Walsh MJ, Zhou MM. Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b. Nature 2010; 466:258-62; PMID:20613843; http:// dx.doi.org/10.1038/nature09139
30. Margueron R, Reinberg D. Chromatin structure and the inheritance of epigenetic information. Nat Rev Genet 2010; 11:285-96; PMID:20300089; http:// dx.doi.org/10.1038/nrg2752
31. Hibiya K, Katsumoto T, Kondo T, Kitabayashi I, Kudo A. Brpf1, a subunit of the MOZ histone acetyl transferase complex, maintains expression of anterior and posterior Hox genes for proper patterning of craniofacial and caudal skeletons. Dev Biol 2009; 329:176-90; PMID:19254709; http://dx.doi. org/10.1016/j.ydbio.2009.02.021
32. Laue K, Daujat S, Crump JG, Plaster N, Roehl HH, Kimmel CB, Schneider R, Hammerschmidt M; Tübingen 2000 Screen Consortium. The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity. Development 2008; 135:1935-46; PMID:18469222; http://dx.doi.org/10.1242/dev.017160
33. Mishima Y, Miyagi S, Saraya A, Negishi M, Endoh M, Endo TA, Toyoda T, Shinga J, Katsumoto T, Chiba T, et al. The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis. Blood 2011; 118:2443-53; PMID:21753189; http://dx.doi. org/10.1182/blood-2011-01-331892
34. Lalonde ME, Avvakumov N, Glass KC, Joncas FH, Saksouk N, Holliday M, Paquet E, Yan K, Tong Q, Klein BJ, et al. Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity. Genes Dev 2013; 27:2009-24; PMID:24065767; http://dx.doi.org/10.1101/gad.223396.113
35. Avvakumov N, Lalonde ME, Saksouk N, Paquet E, Glass KC, Landry AJ, Doyon Y, Cayrou C, Robitaille GA, Richard DE, et al. Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferation. Mol Cell Biol 2012; 32:689-703; PMID:22144582; http://dx.doi. org/10.1128/MCB.06455-11
36. Saksouk N, Avvakumov N, Champagne KS, Hung T, Doyon Y, Cayrou C, Paquet E, Ullah M, Landry AJ, Côté V, et al. HBO1 HAT complexes target chromatin throughout gene coding regions via multiple PHD finger interactions with histone H3 tail. Mol Cell 2009; 33:257-65; PMID:19187766; http://dx.doi. org/10.1016/j.molcel.2009.01.007
37. Qin S, Jin L, Zhang J, Liu L, Ji P, Wu M, Wu J, Shi Y. Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF). J Biol Chem 2011; 286:36944-55; PMID:21880731; http://dx.doi.org/10.1074/jbc.M111.244400
38. Liu L, Qin S, Zhang J, Ji P, Shi Y, Wu J. Solution structure of an atypical PHD finger in BRPF2 and its interaction with DNA. J Struct Biol 2012; 180:165-73; PMID:22820306; http://dx.doi.org/10.1016/j. jsb.2012.06.014
39. Filippakopoulos P, Picaud S, Mangos M, Keates T, Lambert JP, Barsyte-Lovejoy D, Felletar I, Volkmer R, Müller S, Pawson T, et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 2012; 149:214-31; PMID:22464331; http://dx.doi.org/10.1016/j. cell.2012.02.013
40. Vezzoli A, Bonadies N, Allen MD, Freund SM, Santiveri CM, Kvinlaug BT, Huntly BJ, Göttgens B, Bycroft M. Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. Nat Struct Mol Biol 2010; 17:617-9; PMID:20400950; http://dx.doi.org/10.1038/nsmb.1797
41. Musselman CA, Kutateladze TG. Handpicking epigenetic marks with PHD fingers. Nucleic Acids Res 2011; 39:9061-71; PMID:21813457; http://dx.doi. org/10.1093/nar/gkr613
42. Kutateladze TG. Translation of the phosphoinositide code by PI effectors. Nat Chem Biol 2010; 6:507-13; PMID:20559318; http://dx.doi.org/10.1038/ nchembio.390
43. Soliman MA, Riabowol K. After a decade of study-ING, a PHD for a versatile family of proteins. Trends Biochem Sci 2007; 32:509-19; PMID:17949986; http://dx.doi.org/10.1016/j.tibs.2007.08.006
44. Unoki M, Kumamoto K, Harris CC. ING proteins as potential anticancer drug targets. Curr Drug Targets 2009; 10:442-54; PMID:19442116; http://dx.doi. org/10.2174/138945009788185059
45. Maher SK, Helbing CC. Modulators of inhibitor of growth (ING) family expression in development and disease. Curr Drug Targets 2009; 10:392-405; PMID:19442112; http://dx.doi. org/10.2174/138945009788185095
46. Piche B, Li G. Inhibitor of growth tumor suppressors in cancer progression. Cell Mol Life Sci 2010; 67:1987-99; PMID:20195696; http://dx.doi. org/10.1007/s00018-010-0312-z
47. Champagne KS, Saksouk N, Peña PV, Johnson K, Ullah M, Yang XJ, Côté J, Kutateladze TG. The crystal structure of the ING5 PHD finger in complex with an H3K4me3 histone peptide. Proteins 2008; 72:1371-6; PMID:18623064; http://dx.doi. org/10.1002/prot.22140
48. Peña PV, Davrazou F, Shi X, Walter KL, Verkhusha VV, Gozani O, Zhao R, Kutateladze TG. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature 2006; 442:100-3; PMID:16728977
49. Champagne KS, Kutateladze TG. Structural insight into histone recognition by the ING PHD fingers. Curr Drug Targets 2009; 10:432-41; PMID:19442115; http://dx.doi.org/10.2174/138945009788185040
50. Voss AK, Vanyai HK, Collin C, Dixon MP, McLennan TJ, Sheikh BN, Scambler P, Thomas T. MOZ regulates the Tbx1 locus, and Moz mutation partially phenocopies DiGeorge syndrome. Dev Cell 2012; 23:652-63; PMID:22921202; http://dx.doi. org/10.1016/j.devcel.2012.07.010
51. Miller CT, Maves L, Kimmel CB. Moz regulates Hox expression and pharyngeal segmental identity in zebrafish. Development 2004; 131:2443-61; PMID:15128673; http://dx.doi.org/10.1242/ dev.01134
52. Thomas T, Voss AK, Chowdhury K, Gruss P. Querkopf, a MYST family histone acetyltransferase, is required for normal cerebral cortex development. Development 2000; 127:2537-48; PMID:10821753
53. Merson TD, Dixon MP, Collin C, Rietze RL, Bartlett PF, Thomas T, Voss AK. The transcriptional coactivator Querkopf controls adult neurogenesis. J Neurosci 2006; 26:11359-70; PMID:17079664; http://dx.doi. org/10.1523/JNEUROSCI.2247-06.2006
54. Sheikh BN, Dixon MP, Thomas T, Voss AK. Querkopf is a key marker of self-renewal and multipotency of adult neural stem cells. J Cell Sci 2012; 125:295-309; PMID:22331353; http://dx.doi. org/10.1242/jcs.077271
55. Yang XJ. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res 2004; 32:959-76; PMID:14960713; http://dx.doi.org/10.1093/nar/ gkh252
56. Deguchi K, Ayton PM, Carapeti M, Kutok JL, Snyder CS, Williams IR, Cross NC, Glass CK, Cleary ML, Gilliland DG. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell 2003; 3:259-71; PMID:12676584; http://dx.doi.org/10.1016/S1535-6108(03)00051-5
57. Aikawa Y, Katsumoto T, Zhang P, Shima H, Shino M, Terui K, Ito E, Ohno H, Stanley ER, Singh H, et al. PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2. Nat Med 2010; 16:580-5, 1p, 585; PMID:20418886; http://dx.doi.org/10.1038/nm.2122
58. Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N, Rowan R, Amaral S, Curley D, Williams IR, et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004; 6:587-96; PMID:15607963; http://dx.doi. org/10.1016/j.ccr.2004.10.015
59. Moore SD, Herrick SR, Ince TA, Kleinman MS, Dal Cin P, Morton CC, Quade BJ. Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF. Cancer Res 2004; 64:5570-7; PMID:15313893; http://dx.doi.org/10.1158/0008-5472.CAN-04-0050
60. Kraft M, Cirstea IC, Voss AK, Thomas T, Goehring I, Sheikh BN, Gordon L, Scott H, Smyth GK, Ahmadian MR, et al. Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndromelike phenotype and hyperactivated MAPK signaling in humans and mice. J Clin Invest 2011; 121:3479-91; PMID:21804188; http://dx.doi.org/10.1172/ JCI43428
61. Clayton-Smith J, O'Sullivan J, Daly S, Bhaskar S, Day R, Anderson B, Voss AK, Thomas T, Biesecker LG, Smith P, et al. Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome. Am J Hum Genet 2011; 89:675-81; PMID:22077973; http://dx.doi. org/10.1016/j.ajhg.2011.10.008
62. Szakszon K, Salpietro C, Kakar N, Knegt AC, Oláh E, Dallapiccola B, Borck G. De novo mutations of the gene encoding the histone acetyltransferase KAT6B in two patients with Say-Barber/Biesecker/ Young-Simpson syndrome. Am J Med Genet A 2013; 161A:884-8; PMID:23436491; http://dx.doi. org/10.1002/ajmg.a.35848
63. Simpson MA, Deshpande C, Dafou D, Vissers LE, Woollard WJ, Holder SE, Gillessen-Kaesbach G, Derks R, White SM, Cohen-Snuijf R, et al. De novo mutations of the gene encoding the histone acetyltransferase KAT6B cause Genitopatellar syndrome. Am J Hum Genet 2012; 90:290-4; PMID:22265017; http://dx.doi.org/10.1016/j.ajhg.2011.11.024
64. Campeau PM, Kim JC, Lu JT, Schwartzentruber JA, Abdul-Rahman OA, Schlaubitz S, Murdock DM, Jiang MM, Lammer EJ, Enns GM, et al. Mutations in KAT6B, encoding a histone acetyltransferase, cause Genitopatellar syndrome. Am J Hum Genet 2012; 90:282-9; PMID:22265014; http://dx.doi. org/10.1016/j.ajhg.2011.11.023
65. Christensen JH, Elfving B, Müller HK, Fryland T, Nyegaard M, Corydon TJ, Nielsen AL, Mors O, Wegener G, Børglum AD. The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress. Eur Neuropsychopharmacol 2012; 22:651-6; PMID:22341945; http://dx.doi.org/10.1016/j. euroneuro.2012.01.005
66. Nyegaard M, Severinsen JE, Als TD, Hedemand A, Straarup S, Nordentoft M, McQuillin A, Bass N, Lawrence J, Thirumalai S, et al. Support of association between BRD1 and both schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 2010; 153B:582-91; PMID:19693800
67. Fryland T, Elfving B, Christensen JH, Mors O, Wegener G, Børglum AD. Electroconvulsive seizures regulates the Brd1 gene in the frontal cortex and hippocampus of the adult rat. Neurosci Lett 2012; 516:110-3; PMID:22675730; http://dx.doi. org/10.1016/j.neulet.2012.03.069
68. Nebral K, Denk D, Attarbaschi A, König M, Mann G, Haas OA, Strehl S. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia. Leukemia 2009; 23:134-43; PMID:19020546; http://dx.doi.org/10.1038/leu.2008.306
69. Li X, Kikuchi K, Takano Y. ING Genes Work as Tumor Suppressor Genes in the Carcinogenesis of Head and Neck Squamous Cell Carcinoma. J Oncol 2011; 2011:963614; PMID:21052543; http://dx.doi. org/10.1155/2011/963614
70. Cengiz B, Gunduz E, Gunduz M, Beder LB, Tamamura R, Bagci C, Yamanaka N, Shimizu K, Nagatsuka H. Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma. Int J Cancer 2010; 127:2088-94; PMID:20131318; http://dx.doi.org/10.1002/ ijc.25224
71. Xing YN, Yang X, Xu XY, Zheng Y, Xu HM, Takano Y, Zheng HC. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression. Hum Pathol 2011; 42:25-35; PMID:21062663; http://dx.doi.org/10.1016/j. humpath.2010.05.024